Elevated Serum IL-2 Levels Are Associated With Major Depressive Disorder: A Case-Control Study

Overview

Journal Clin Pathol

Publisher Sage Publications

Date 2023 Jun 26

PMID 37360518

Authors

Farhana Islam Suhee

Mohammad Shahriar

Sardar Mohammad Ashraful Islam

Mohiuddin Ahmed Bhuiyan

Md Rabiul Islam

Affiliations

Soon will be listed here.

Abstract

Objectives: Numerous earlier studies have stated an association between major depressive disorder (MDD) and altered expression of inflammatory process. However, it still needs to determine whether the alteration of cytokines is the causative factor or a consequence of this disorder. Therefore, we attempted to evaluate the role of the pro-inflammatory cytokine IL-2 in the pathophysiology of depression.

Methods: We collected blood samples from 111 MDD patients and 112 healthy controls (HCs) matched by age and sex. Diagnostic and statistical manual of mental disorders (DSM-5) score was used to assess study participants. We determined the severity of depression using the Hamilton Depression (Ham-D) rating scale. We assayed serum levels of IL-2 using the Enzyme-Linked Immunosorbent Assay (ELISA) kit.

Results: Elevated levels of IL-2 were detected in MDD patients than HCs (29.79 ± 6.18 and 12.77 ± 4.84 pg/ml, < 0.05). We observed a higher level of IL-2 in female MDD patients compared to female HCs (31.98 ± 8.34 and 7.76 ± 0.36 pg/ml, < 0.05). We witnessed a sex-specific correlation between the serum IL-2 levels and the Ham-D score and found that the females with higher Ham-D scores had higher serum IL-2 levels. Moreover, the ROC curve represented the good diagnostic performance of serum IL-2 levels as a biomarker with sensitivity and specificity values of 83.7% and 80.4%, respectively.

Conclusions: The current study findings indicate that elevated serum IL-2 levels are associated with MDD. This alteration may be the cause of triggering depression or a result of the activated inflammatory process during the depression. Therefore, we recommend further interventional research to clarify the actual reasons for these altered IL-2 levels in MDD patients.

Citing Articles

Ketamine Prevents Inflammation-Induced Reduction of Human Hippocampal Neurogenesis via Inhibiting the Production of Neurotoxic Metabolites of the Kynurenine Pathway.

Mandal G, Kirkpatrick M, Alboni S, Mariani N, Pariante C, Borsini A Int J Neuropsychopharmacol. 2024; 27(10).

PMID: 39297528 PMC: 11450635. DOI: 10.1093/ijnp/pyae041.

Inflammatory Hematological Ratios in Adolescents with Mental Disorders: A Scoping Review.

Popov M, Popov Y, Kosterin D, Lepik O Consort Psychiatr. 2024; 5(2):45-61.

PMID: 39071999 PMC: 11272303. DOI: 10.17816/CP15514.

Association of interleukin-2 and interleukin-10 with the pathophysiology and development of generalized anxiety disorder: a case-control study.

Sarmin N, Roknuzzaman A, Sarker R, -Or-Rashid M, Qusar M, Bachar S BMC Psychiatry. 2024; 24(1):462.

PMID: 38902708 PMC: 11188505. DOI: 10.1186/s12888-024-05911-z.

Evaluation of serum MIP-1β and MCP-2 levels in major depressive disorder: A case-control study.

Akter M, Roknuzzaman A, Shahriar M, Islam S, Bhuiyan M, Qusar M PLoS One. 2024; 19(6):e0305734.

PMID: 38889138 PMC: 11185482. DOI: 10.1371/journal.pone.0305734.

Transcriptomic Evaluation of a Stress Vulnerability Network Using Single-Cell RNA Sequencing in Mouse Prefrontal Cortex.

Hing B, Mitchell S, Filali Y, Eberle M, Hultman I, Matkovich M Biol Psychiatry. 2024; 96(11):886-899.

PMID: 38866174 PMC: 11524784. DOI: 10.1016/j.biopsych.2024.05.023.

References

Breslau N . Depressive symptoms, major depression, and generalized anxiety: a comparison of self-reports on CES-D and results from diagnostic interviews. Psychiatry Res. 1985; 15(3):219-29. DOI: 10.1016/0165-1781(85)90079-4. View

Felger J, Lotrich F . Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience. 2013; 246:199-229. PMC: 3741070. DOI: 10.1016/j.neuroscience.2013.04.060. View

Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim E . A meta-analysis of cytokines in major depression. Biol Psychiatry. 2009; 67(5):446-57. DOI: 10.1016/j.biopsych.2009.09.033. View

Zhang J, An J . Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007; 45(2):27-37. PMC: 2785020. DOI: 10.1097/AIA.0b013e318034194e. View

Wang L, Wang R, Liu L, Qiao D, Baldwin D, Hou R . Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis. Brain Behav Immun. 2019; 79:24-38. DOI: 10.1016/j.bbi.2019.02.021. View

Levinson D, Lakoma M, Petukhova M, Schoenbaum M, Zaslavsky A, Angermeyer M . Associations of serious mental illness with earnings: results from the WHO World Mental Health surveys. Br J Psychiatry. 2010; 197(2):114-21. PMC: 2913273. DOI: 10.1192/bjp.bp.109.073635. View

Raison C, Rutherford R, Woolwine B, Shuo C, Schettler P, Drake D . A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2012; 70(1):31-41. PMC: 4015348. DOI: 10.1001/2013.jamapsychiatry.4. View

Dunn A, Swiergiel A, de Beaurepaire R . Cytokines as mediators of depression: what can we learn from animal studies?. Neurosci Biobehav Rev. 2005; 29(4-5):891-909. DOI: 10.1016/j.neubiorev.2005.03.023. View

Pariante C . Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids. Ann N Y Acad Sci. 2009; 1179:144-52. PMC: 2982725. DOI: 10.1111/j.1749-6632.2009.04978.x. View

10.

Hockey M, Mohebbi M, Tolmunen T, Hantunen S, Tuomainen T, Macpherson H . Associations between total dairy, high-fat dairy and low-fat dairy intake, and depressive symptoms: findings from a population-based cross-sectional study. Eur J Nutr. 2022; 62(1):227-237. PMC: 9899713. DOI: 10.1007/s00394-022-02950-8. View

11.

Nishuty N, Khandoker M, Karmoker J, Ferdous S, Shahriar M, Qusar M . Evaluation of Serum Interleukin-6 and C-reactive Protein Levels in Drug-naïve Major Depressive Disorder Patients. Cureus. 2019; 11(1):e3868. PMC: 6414189. DOI: 10.7759/cureus.3868. View

12.

Daria S, Proma M, Shahriar M, Islam S, Bhuiyan M, Islam M . Serum interferon-gamma level is associated with drug-naïve major depressive disorder. SAGE Open Med. 2020; 8:2050312120974169. PMC: 7682211. DOI: 10.1177/2050312120974169. View

13.

Kessler R, Heeringa S, Lakoma M, Petukhova M, Rupp A, Schoenbaum M . Individual and societal effects of mental disorders on earnings in the United States: results from the national comorbidity survey replication. Am J Psychiatry. 2008; 165(6):703-11. PMC: 2410028. DOI: 10.1176/appi.ajp.2008.08010126. View

14.

Raison C, Borisov A, Majer M, Drake D, Pagnoni G, Woolwine B . Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry. 2008; 65(4):296-303. PMC: 2655138. DOI: 10.1016/j.biopsych.2008.08.010. View

15.

Zhu S, Zhao L, Fan Y, Lv Q, Wu K, Lang X . Interaction between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia. Psychoneuroendocrinology. 2020; 114:104595. DOI: 10.1016/j.psyneuen.2020.104595. View

16.

Ford E, Clark C, McManus S, Harris J, Jenkins R, Bebbington P . Common mental disorders, unemployment and welfare benefits in England. Public Health. 2010; 124(12):675-81. DOI: 10.1016/j.puhe.2010.08.019. View

17.

Allison D, Ditor D . The common inflammatory etiology of depression and cognitive impairment: a therapeutic target. J Neuroinflammation. 2014; 11:151. PMC: 4156619. DOI: 10.1186/s12974-014-0151-1. View

18.

Rahman S, Shanta A, Daria S, Nahar Z, Shahriar M, Qusar M . Increased serum resistin but not G-CSF levels are associated in the pathophysiology of major depressive disorder: Findings from a case-control study. PLoS One. 2022; 17(2):e0264404. PMC: 8880862. DOI: 10.1371/journal.pone.0264404. View

19.

Kim Y, Na K, Shin K, Jung H, Choi S, Kim J . Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007; 31(5):1044-53. DOI: 10.1016/j.pnpbp.2007.03.004. View

20.

Das R, Emon M, Chowdhury S, Huque S, Zahan T, Islam M . Evaluation of Serum Glial Cell Line-derived Neurotrophic Factor in Bangladeshi Major Depressive Disorder Patients. Cureus. 2019; 11(11):e6081. PMC: 6894901. DOI: 10.7759/cureus.6081. View